Richard Lee

Richard Lee is an experienced executive in the pharmaceutical industry, currently serving as Executive Director at Verve Therapeutics since September 2021, where work focuses on developing cardiovascular therapeutics using a gene editing platform. Prior to this role, Richard held multiple positions at Ionis Pharmaceuticals, Inc. from February 2007 to August 2021, culminating in the role of Executive Director, and was a key member of the Cardiovascular Drug Discovery Team. Earlier in Richard's career, experience includes a position as Senior Scientist and Postdoctoral Fellow at UCLA from February 2005 to February 2007. Richard Lee holds a PhD in Cellular and Molecular Pathobiology from Wake Forest University School of Medicine and a Bachelor's degree in Biology from Western Oregon University.